Koxinga Investments Fixed Income

Koxinga Investments Fixed Income for me to share my analysis and news I find interesting, and hopefully learn from any comments and feedback. This page is mostly about FIxed Income.

This page is for me to share my ad-hoc analysis on fixed income (mostly rates/govvies, FX and sometimes equity indices) for investment purposes. Also hopefully, a page for me to learn from comments and other like-minded individuals who take time to read my posts and provide valuable insights.

10th December 2021 : US Inflation Markets pricing in the highest CPI (inflation) of 6.8% since 1982 (~40yrs), with print...
10/12/2021

10th December 2021 : US Inflation Markets pricing in the highest CPI (inflation) of 6.8% since 1982 (~40yrs), with print coming in UTC 1330pm. Rate hikes in US rates priced-in half of nx year 2022.

This is on sustained high inflation over the past 6 months; and the term 'transitionary' had been retired from Fed speech in the last hearing.

Is the Fed about to make a Policy Error?https://www.reuters.com/world/us/feds-bostic-says-he-favors-balanced-fast-approa...
13/08/2021

Is the Fed about to make a Policy Error?

https://www.reuters.com/world/us/feds-bostic-says-he-favors-balanced-fast-approach-tapering-2021-08-09/

Understandably, with recent Inflation print surging to all-time highs (latest few prints show between 9% to almost 20% year-on-year depending on the metric), markets are betting on earlier tapering (and then rate hikes).

Interestingly, (rates) option traders are betting on a tail-event, which follows the previous taper-tantrum narrative.

Namely, there are huge Call-Options on Mar-2025 Fed -rates at 0.5% (compared to current market-pricing of 1.46%); with the concentrated expiry of March 2022.

Word-on-the-street bet on this option is : Fed tries to taper due to Inflation concerns, but (equity) market crashes and the Fed is then forced to walk-back on tapering... which by default, then collapses any chance of future rate hikes.

14/12/2020

An executive order by the U.S. President led to indices providers taking pre-emptive actions and we saw heavy selling pressure on certain Chinese stocks ahead of complications.

JD Health surged on its public debut but shareholders of JD.com weren't pleased. I argue this is a buying opportunity for JD.com and I ate my own cooking.

While the valuation of JD Health has multiplied several times in a year, there appears to be much more room to grow and I initiated a position.

The jump in Baidu's share price sent it to the resistance level of its multi-month uptrend channel.

Fundamentally and operationally, there are recent developments to like. Short-term wise, there could be some pullback but longer-term, the uptrend seems intact.

Shareholders with a longer-term view should rejoice at the opportunity to grab more shares of JD.com at a deepening sum-of-the-parts discount.

02/08/2020

You will be able to access my monthly subscription service.
In the service, I provide up to 2 actionable investment trading strategies each day.
The signal will have entry/exit/stoploss/time-horizon.

Please read the disclaimer in the picture attached. I cannot be liable or responsible for your decisions to act/not-act on the signals provided; which are there for informational purposes.

Address

London
EC1A1HQ

Website

Alerts

Be the first to know and let us send you an email when Koxinga Investments Fixed Income posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Koxinga Investments Fixed Income:

Share